GENERAC HOLDINGS INC. Income Taxes Disclosure
| 15. | Income Taxes |
The Company’s provision for income taxes consists of the following:
| Year Ended December 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Income (Loss) from continuing operations before income tax expense (benefit) | ||||||||||||
| U.S. Federal | $ | 137,475 | $ | 369,150 | $ | 218,371 | ||||||
| Foreign | 61,585 | 40,288 | 71,929 | |||||||||
| Total | $ | 199,060 | $ | 409,438 | $ | 290,300 | ||||||
| Income tax expense / (benefit) from continuing operations | ||||||||||||
| Current: | ||||||||||||
| Federal | $ | 10,045 | $ | 117,749 | $ | 71,741 | ||||||
| State | (2,825 | ) | 20,970 | 13,802 | ||||||||
| Foreign | 15,406 | 14,356 | 22,115 | |||||||||
| Total current tax expense | 22,626 | 153,075 | 107,658 | |||||||||
| Deferred: | ||||||||||||
| Federal | 17,913 | (46,526 | ) | (26,504 | ) | |||||||
| State | 3,109 | (8,613 | ) | (5,254 | ) | |||||||
| Foreign | (7,255 | ) | (5,565 | ) | (3,218 | ) | ||||||
| Total deferred tax expense (benefit) | 13,767 | (60,704 | ) | (34,976 | ) | |||||||
| Total income tax expense | ||||||||||||
| Federal | 27,958 | 71,223 | 45,237 | |||||||||
| State and local | 284 | 12,357 | 8,548 | |||||||||
| Foreign | 8,151 | 8,791 | 18,897 | |||||||||
| Total income tax expense | 36,393 | 92,371 | 72,682 | |||||||||
| Change in valuation allowance | 1,313 | 89 | 498 | |||||||||
| Provision for income taxes | $ | 37,706 | $ | 92,460 | $ | 73,180 | ||||||
The Company files U.S. federal, U.S. state and foreign jurisdiction tax returns which are subject to examination up to the expiration of the statute of limitations. The Company believes the tax positions taken on its returns would be sustained upon an exam, or where a position is uncertain, adequate reserves have been recorded. As of December 31, 2025, the Company is no longer subject to income tax examinations for United States federal income taxes for tax years prior to For Wisconsin state income taxes, the statute of limitation is generally four years from the date the tax return is filed, unless the Company carries over certain tax attributes that were generated in prior years (e.g., net operating losses and R&D credits), then the state may also review those years to validate the tax attributes. The Company has utilized net operating losses or R&D credits on their state income tax returns since 2007. In addition, the Company is subject to audit by various foreign taxing jurisdictions for tax years through 2024.
The Company is regularly under tax return examination by tax authorities in the various jurisdictions in which we operate. The Company is actively managing the examinations and working to address any open matters. While the Company does not believe any material taxes or penalties are due, there is a possibility that the ultimate tax outcome of an examination may result in differences from what was recorded. Such differences may affect the provision for income taxes in the period in which the determination is made and could impact the Company’s financial results.
Significant components of deferred tax assets and liabilities are as follows:
| December 31, | ||||||||
| 2025 | 2024 | |||||||
| Deferred tax assets: | ||||||||
| Accrued expenses | $ | 54,731 | $ | 52,351 | ||||
| Deferred revenue | 39,679 | 43,261 | ||||||
| Inventories | 17,853 | 14,103 | ||||||
| Stock-based compensation | 8,633 | 16,959 | ||||||
| Operating loss and credit carryforwards | 55,585 | 50,327 | ||||||
| Debt refinancing costs | 446 | - | ||||||
| Bad debt | 1,218 | 1,803 | ||||||
| Other | 12,829 | 13,031 | ||||||
| Capitalized R&D | 30,605 | 98,323 | ||||||
| Prepaid expenses | 1,268 | - | ||||||
| Valuation allowance | (6,538 | ) | (5,225 | ) | ||||
| Total deferred tax assets | 216,309 | 284,933 | ||||||
| Deferred tax liabilities: | ||||||||
| Goodwill and intangible assets | 183,106 | 234,271 | ||||||
| Depreciation | 52,001 | 49,935 | ||||||
| Interest Swap, Derivative | 166 | 6,496 | ||||||
| Prepaid expenses | - | 3,284 | ||||||
| Total deferred tax liabilities | 235,273 | 293,986 | ||||||
| Net deferred tax liabilities | $ | (18,964 | ) | $ | (9,053 | ) | ||
As of December 31, 2025 and 2024, deferred tax assets of $41,949 and $24,132, and deferred tax liabilities of $60,913 and $33,185, respectively, were reflected in the consolidated balance sheets.
The Company maintains a $6,538 valuation allowance against the deferred tax assets primarily related to certain tax loss carryforwards which may not be realized. Realization of the deferred income tax asset related to the tax loss carryforward is dependent upon generating sufficient taxable income in these jurisdictions prior to their expiration. During 2025, the valuation allowance increased by $1,313 on our deferred tax assets where we believe the tax asset may not be fully utilized.
At December 31, 2025, the Company had tax loss carryforwards of approximately $197,981, which have varying expiration periods ranging from 2025 to indefinite. For carryforward amounts which the Company believes the losses will expire prior to use, a valuation allowance has been established. For all other carryforwards, the Company believes it will generate sufficient taxable income in these jurisdictions to utilize its loss carryforwards prior to their expiration.
At December 31, 2025, the Company had state manufacturing investment tax credit carryforwards of approximately $31,871, which expire between 2028 and 2040. The Company believes it will generate sufficient taxable income in these jurisdictions to fully utilize the credits prior to their expiration.
Changes in the Company’s gross liability for unrecognized tax benefits, excluding interest and penalties, were as follows:
| December 31, | ||||||||
| 2025 | 2024 | |||||||
| Unrecognized tax benefit, beginning of period | $ | 11,178 | $ | 9,703 | ||||
| Increase in unrecognized tax benefit for positions taken in prior period | 745 | 1,068 | ||||||
| Increase in unrecognized tax benefit for positions taken in current period | 1,402 | 943 | ||||||
| Statute of limitation expirations | (721 | ) | (536 | ) | ||||
| Settlements | - | - | ||||||
| Unrecognized tax benefit, end of period | $ | 12,604 | $ | 11,178 | ||||
The unrecognized tax benefit as of December 31, 2025 and 2024, if recognized, would favorably impact the effective tax rate.
As of December 31, 2025 and 2024, total accrued interest of approximately $1,736 and $1,142, respectively, and accrued penalties of approximately $1,080 and $954, respectively, associated with net unrecognized tax benefits are included in the consolidated balance sheets. Interest and penalties are recorded as a component of income tax expense.
The Company does not expect a significant change to the total amount of unrecognized tax benefits during the fiscal year ending December 31, 2026.
A reconciliation of the U.S. federal statutory tax rate to the effective tax rate for the years ended December 31, 2025, 2024 and 2023 is as follows:
| Year Ended December 31, | ||||||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||||||
| Earnings from continuing operations, before income tax expense | $ | 199,060 | $ | 409,438 | $ | 290,300 | ||||||||||||||||||
| Tax provision at the U.S. federal statutory rate | $ | 41,803 | 21.0 | % | $ | 85,982 | 21.0 | % | $ | 60,963 | 21.0 | % | ||||||||||||
| Federal | ||||||||||||||||||||||||
| Effect of cross-border tax laws | (1,857 | ) | % | (974 | ) | % | 4,180 | % | ||||||||||||||||
| Tax Credits | ||||||||||||||||||||||||
| Research and Development Credit | (7,252 | ) | % | (5,533 | ) | % | (7,361 | ) | % | |||||||||||||||
| Other Credits | (310 | ) | % | (485 | ) | % | (1,403 | ) | % | |||||||||||||||
| Changes in valuation allowances | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | |||||||||||||||
| Nontaxable or nondeductible items | ||||||||||||||||||||||||
| Share-based compensation expense (benefit) | 7,584 | % | (4,720 | ) | % | (1,102 | ) | % | ||||||||||||||||
| Nondeductible U.S. compensation expense | 1,003 | 0.5 | % | 4,369 | 1.1 | % | 3,648 | 1.3 | % | |||||||||||||||
| Worthless Stock Deduction | (6,463 | ) | % | - | % | - | % | |||||||||||||||||
| Effect of changes in tax laws or rates enacted in current period | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | |||||||||||||||
| Other | 870 | % | (2,279 | ) | % | 3,350 | % | |||||||||||||||||
| Foreign Tax Effects | (1,329 | ) | % | 2,683 | % | 1,288 | % | |||||||||||||||||
| State and local income tax, net of federal income tax benefit (1) | 1,837 | 0.9 | % | 11,452 | 2.8 | % | 7,151 | 2.5 | % | |||||||||||||||
| Changes in unrecognized tax benefits | 1,820 | 0.9 | % | 1,965 | 0.5 | % | 2,466 | 0.8 | % | |||||||||||||||
| Income tax expense | $ | 37,706 | 18.9 | % | $ | 92,460 | 22.6 | % | $ | 73,180 | 25.2 | % | ||||||||||||
| (1) | During the year ended December 31, 2025, state taxes and credits in South Carolina, Wisconsin, California, Illinois, Pennsylvania, New York, Georgia, Michigan, New Jersey, Florida, Massachusetts, Texas, Indiana, Maine, Connecticut comprised greater than 50% of the tax effect in this category. |
Income taxes paid are as follows:
| Year Ended December 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| U.S Federal | $ | 58,803 | $ | 113,496 | $ | 32,886 | ||||||
| Total U.S. State and Local | 15,132 | 17,973 | 12,003 | |||||||||
| United Kingdom (1) | 8,731 | - | 5,951 | |||||||||
| Canada (2) | - | - | 36,560 | |||||||||
| Other | 6,749 | 17,359 | 12,682 | |||||||||
| Total Foreign | 15,480 | 17,359 | 55,193 | |||||||||
| Total income taxes paid, net | $ | 89,415 | $ | 148,828 | $ | 100,082 | ||||||
| (1) | The amount of income taxes paid during the year ended December 31, 2024 does not meet the 5% disaggregation threshold. |
| (2) | The amount of income taxes paid during the years ended December 31, 2025 and 2024 does not meet the 5% disaggregation threshold. |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 18, 2026 | Showing above |
| 2024 | Feb 19, 2025 | |
| 2023 | Feb 21, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 22, 2022 | |
| 2020 | Feb 23, 2021 | |
| 2019 | Feb 25, 2020 | |
| 2018 | Feb 26, 2019 | |
| 2017 | Feb 26, 2018 | |
| 2016 | Feb 24, 2017 | |
| 2015 | Feb 26, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.